stemcell
Enter to win 1 of 4 $500 USD travel awards to the ISSCR Annual Meeting in Melbourne, June 2018.
The Niche

The Niche

Knoepfler lab stem cell blog

  • Home
  • Contact
  • About Us
  • The Lab
  • Trial search
  • Stem cells in your language
  • Treatments
  • Stem Cell Book
  • TED talk
  • Nature
  • Clinic List
  • CRISPR
  • Privacy Policy
  • 2018 Stem Cell Meetings
  • RMAT List

stemophile

Mesoblast stock

Stem cell news bites: Mesoblast, BioTime, MS, FDA Warning, & More

June 14, 2016 admin 4

Stem cell studies continue to make big news with a mixed bag of trends, and some good stem cell news and others not so much. Mesoblast ($MESO) had its stock suspended for quite so time recently in anticipation of a […]

Subscribe to this Blog

Join 21,147 other subscribers

  • RSS - Posts
  • RSS - Comments

Recent Comments

  • admin on Sen. Grassley asks tough questions for FDA on U.S. Stem Cell, blinded women
  • John on Sen. Grassley asks tough questions for FDA on U.S. Stem Cell, blinded women
  • Aron Miller on Analysis: human immunity to Cas9 bigger #CRISPR therapeutic hurdle than off-targets?
  • Bertram the Redneck Cowboy on Sen. Grassley asks tough questions for FDA on U.S. Stem Cell, blinded women
  • T on Sen. Grassley asks tough questions for FDA on U.S. Stem Cell, blinded women

Blogroll

  • BioPolitical Times
  • California Stem Cell Report
  • Cell Trials
  • CIRM Blog
  • EuroStemCell
  • msemporda
  • RetractionWatch
  • Signals Blog
  • Stem Cell Battles
  • Stem Cells Portal
  • The Node

Copyright © 2018 | Designwork by Tradesouthwest Top